Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1977 Sep 10;2(6088):688–690. doi: 10.1136/bmj.2.6088.688

Arterial embolism in thyrotoxicosis with atrial fibrillation.

J S Staffurth, M C Gibberd, S N Fui
PMCID: PMC1631908  PMID: 902055

Abstract

In 262 patients with thyrotoxicosis and atrial fibrillation there were 26 episodes of arterial embolism (17 cerebral and nine elsewhere) in 21 patients. Twelve incidents occurred with active thyrotoxicosis, three on reversion to sinus rhythm, and 11 after the patients were euthyroid. This important complication is more common than is realised, and most patients should be put on prophylactic anticoagulants when first seen with atrial fibrillation.

Full text

PDF
688

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Carter A. B. Prognosis of cerebral embolism. Lancet. 1965 Sep 11;2(7411):514–519. doi: 10.1016/s0140-6736(65)91473-x. [DOI] [PubMed] [Google Scholar]
  2. Davis P. J., Davis F. B. Hyperthyroidism in patients over the age of 60 years. Clinical features in 85 patients. Medicine (Baltimore) 1974 May;53(3):161–181. doi: 10.1097/00005792-197405000-00001. [DOI] [PubMed] [Google Scholar]
  3. JERVELL A. Auricular fibrillation in thyrotoxicosis, with special regard to the indication for quinidine therapy. Acta Med Scand Suppl. 1952;266:585–593. doi: 10.1111/j.0954-6820.1952.tb13408.x. [DOI] [PubMed] [Google Scholar]
  4. MALOOF F., CHAPMAN E. M. Responses to radioactive iodine therapy in hyperthyroidism, with special reference to cardiac problems. J Clin Endocrinol Metab. 1951 Nov;11(11):1296–1322. doi: 10.1210/jcem-11-11-1296. [DOI] [PubMed] [Google Scholar]
  5. MCGIRR E. M., THOMSON J. A., MURRAY I. P. RADIOIODINE THERAPY IN THYROTOXICOSIS; A REVIEW OF 908 CASES. Scott Med J. 1964 Dec;9:505–513. doi: 10.1177/003693306400901201. [DOI] [PubMed] [Google Scholar]
  6. McCarthy C., Varghese P. J., Barritt D. W. Prognosis of atrial arrhythmias treated by electrical counter shock therapy. A three-year follow-up. Br Heart J. 1969 Jul;31(4):496–500. doi: 10.1136/hrt.31.4.496. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Parker J. L., Lawson D. H. Death from thyrotoxicosis. Lancet. 1973 Oct 20;2(7834):894–895. doi: 10.1016/s0140-6736(73)92019-9. [DOI] [PubMed] [Google Scholar]
  8. SANDLER G., WILSON G. M. The nature and prognosis of heart disease in thyrotoxicosis. A review of 150 patients treated with 131 I. Q J Med. 1959 Jul;28:347–369. [PubMed] [Google Scholar]
  9. SILVER S., DELIT C., ELLER M. The treatment of thyrocardiac disease with radioactive iodine. Prog Cardiovasc Dis. 1962 Jul;5:64–80. doi: 10.1016/s0033-0620(62)80005-x. [DOI] [PubMed] [Google Scholar]
  10. Staffurth J. S., Gibberd M. C., Hilton P. J. Atrial fibrillation in thyrotoxicosis treated with radioiodine. Postgrad Med J. 1965 Nov;41(481):663–671. doi: 10.1136/pgmj.41.481.663. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Vital Statistics. Br Med J. 1959 Jan 24;1(5116):244–245. [PMC free article] [PubMed] [Google Scholar]
  12. WOOD P. An appreciation of mitral stenosis. I. Clinical features. Br Med J. 1954 May 8;1(4870):1051–contd. doi: 10.1136/bmj.1.4870.1051. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES